HVTN 505 vaccine induced antibodies nonspecific for HIV
A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...
Jul 30, 2015
0
72